Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets

Rhea-AI Summary

Better Choice Company (NYSE: BTTR) announced a memorandum of understanding (MOU) signed by Aimia Pet HealthCo. Inc. with KGK Science Inc. for the development of a GLP1 supplement for pets. The MOU outlines KGK's research and development of a GLP1 supplement for use in companion animals, aiming to address obesity and other health issues in overweight pets. KGK is a leading Canadian research organization with expertise in clinical trials and regulatory support. Better Choice sees this as a significant opportunity for the pet health industry and is working to become a pioneer in this sector.

TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo. Inc. (APH), has signed a memorandum of understanding (MOU) with KGK Science Inc. (KGK) for the development of a GLP1 supplement for pets.

The MOU sets out the basis for KGK to commence research and development of a GLP1 supplement for use in companion animals. Combining a GLP1 supplement with Better Choices’ Halo branded toppers or treats for dogs and cats to treat obesity and other health issues associated with overweight pets is an area of growing interest as more than half of dogs and cats worldwide are classified as overweight or obese.

KGK is a leading Canadian researcher organization that provides high-quality clinical research trials and expert regulatory support to several industries. For over 25 years, KGK has successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies to move products efficiently into global markets. KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies.

“We are pleased to make progress with our R&D partners APH and KGK. We see the use of the GLP1 supplement as a significant opportunity for the pet health industry and are assembling top tier partners to help Better Choice and our brands, including Halo, become pioneers in this sector,” commented Michael Young, Chairman of the Board of Directors of Better Choice.

About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including foods, treats, toppers, dental products, chews, and supplements. We have a demonstrated, multi-decade track record of success and are well positioned to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. Our products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. Halo’s core products are made with high-quality, thoughtfully sourced ingredients for natural, science-based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. For more information, please visit https://www.betterchoicecompany.com. 

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
Better Choice Company Inc.
Kent Cunningham, CEO

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com 

What is the MOU announced by Better Choice Company (BTTR)?

The MOU is a memorandum of understanding signed by Aimia Pet HealthCo. Inc. with KGK Science Inc. for the development of a GLP1 supplement for pets, aiming to address obesity and other health issues in overweight pets.

Who is KGK Science Inc. and what is their expertise?

KGK Science Inc. is a leading Canadian research organization with expertise in clinical trials and regulatory support for various industries.

Why is the development of a GLP1 supplement for pets significant?

The development of a GLP1 supplement for pets is significant as it aims to address obesity and other health issues in overweight pets, which is a growing concern globally.

What is Better Choice Company's goal in this partnership?

Better Choice aims to become a pioneer in the pet health industry by leveraging the development of the GLP1 supplement for pets.